More Company News

Mereo BioPharma

Mereo strengthens management team
30 Jun 2020Read More

Mereo BioPharma

Result of General Meeting
30 Jun 2020Read More

Mereo BioPharma

FY19 results
16 Jun 2020Read More

Mereo BioPharma

Completion of $70m private placement
04 Jun 2020Read More

Mereo BioPharma

Notice of AGM
27 May 2020Read More

Mereo BioPharma

Positive Type B end of Phase II FDA feedback & outlines Phase III paediatric study
28 Feb 2020Read More

Mereo BioPharma

$3m investment from new US Institutional Investor
19 Feb 2020Read More

Mereo BioPharma

Agreement with Novartis and Aspire Capital Fund
10 Feb 2020Read More

Mereo BioPharma

Additional positive data from Phase 2b ASTEROID study
14 Jan 2020Read More

Mereo BioPharma

Mereo and Oncologie enter global licensing agreement for navicixizumab
13 Jan 2020Read More

1 2 3 4
Return to Mereo BioPharma
© 2019-20 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).